10 active trials 4 recruiting 4 Phase 3 7 disease areas
| Early Phase 1 | 1 | |
| Phase 1 | 2 | |
| Phase 1/2 | 1 | |
| Phase 2 | 2 | |
| Phase 2/3 | 1 | |
| Phase 3 | 3 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT06647862 | IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic… | Chronic Myelomonocytic Leukemia | Recruiting | 2025-11-25 |
| NCT07355283 | IMM0306 in Combination With Lenalidomide vs Placebo in Combination With Lenalidomide in… | Relapsed/Refractory Follicular Lymphoma | Not Yet Recruiting | 2026-01-27 |
| NCT06465446 | A Study of IMM01 Plus Tiselizumab Versus Physician's Choice Chemotherapy in… | Classic Hodgkin Lymphoma | Not Yet Recruiting | 2024-06-24 |
| Phase 2/3 | ||||
| NCT07621939 | A Study of IMM0306 in IgG4-Related Disease | IgG4-Related Disease | Not Yet Recruiting | 2026-06-02 |
| Phase 2 | ||||
| NCT07687914 | A Study of IMM2510 + IMM27M Combination Therapy in Patients With Advanced Hepatocellular… | HCC - Hepatocellular Carcinoma | Not Yet Recruiting | 2026-07-07 |
| NCT06746870 | A Phase II Clinical Study to Evaluate the Safety, Pharmacokinetic Profile, and… | NSCLC | Not Yet Recruiting | 2024-12-24 |
| Phase 1/2 | ||||
| NCT07170787 | A Study of IMM2510 + IMM01 Combination Therapy in Patients With Advanced Solid Tumors | Advanced Solid Tumors | Not Yet Recruiting | 2025-09-12 |
| Phase 1 | ||||
| NCT07118085 | A Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Phase… | Healthy Postmenopausal Women | Recruiting | 2025-12-15 |
| NCT06764836 | A Study of IMM2510 + IMM27M Combination Therapy in Patients With Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | 2025-01-08 |
| Early Phase 1 | ||||
| NCT06788431 | A Clinical Study of IMC-001 for Injection in Improving Atherosclerotic Plaque Stability… | Atherosclerosis | Recruiting | 2026-04-15 |
Liver Cancer (2) · Follicular Lymphoma (1) · Hodgkin Lymphoma (1) · Leukemia (1) · MDS/MPN Overlap (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Triple-Negative Breast Cancer (1)